Cite

    Evangeline Samuel et al.. “Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer.” European journal of cancer, vol. 136, 2020, pp. 206–. http://access.bl.uk/ark:/81055/vdc_100105907333.0x000024